Clinical Trial Update: Proof of Mechanism in ELT [Phase 1]

View source ↗

Summary

A Phase 1 study in premature ejaculation completed. The trial reported proof of mechanism for the ELT program.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Ejaculation

Drugs mentioned

• ELT

Snippet

Sponsor: GlaxoSmithKline | Conditions: Premature Ejaculation | Phase 1 | Status: COMPLETED